| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.0M | — | -40.5% |
| Cost of Revenue | $3.7M | — | -44.1% |
| Gross Profit | $582K | — | +293.2% |
| R&D Expense | $156K | — | +95.0% |
| SG&A Expense | $2.4M | — | +1.3% |
| Operating Income | -$2.0M | — | +13.9% |
| Pre-tax Income | -$2.5M | — | -20.8% |
| Net Income | -$2.5M | — | -170.0% |
| EPS (Basic) | -$0.23 | — | -155.6% |
| EPS (Diluted) | -$0.23 | — | -155.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $3.4M | +7.3% | -37.1% |
| Inventory | $5.8M | -7.6% | -9.6% |
| Current Assets | $23.7M | -7.1% | -38.6% |
| Total Assets | $33.0M | -6.9% | -30.4% |
| Current Liabilities | $5.1M | +4.0% | -59.3% |
| Total Liabilities | $6.2M | +1.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$887K | — | -159.1% |
| Capital Expenditures | $233K | — | -60.8% |
| Investing Cash Flow | -$459K | — | +22.9% |
| Financing Cash Flow | -$30K | — | +99.8% |
| Free Cash Flow | -$1.1M | — | -223.5% |
| -52.2% |
| Stockholders' Equity | $26.8M | -8.5% | -22.3% |